InvestorsHub Logo
icon url

The Rainbow

07/06/20 1:39 PM

#14159 RE: AdamS007 #14155

Yes, the poor $BDX performance is actually surprising at this late stage in development.

Also,the Becton Dickinson CEO realizes their test is very expensive at $20.00 per test. He tried to minimize the expense because it is 50% cheaper than the current PCR tests.

$ABMC should get some traction from this exposure when it is found to be better performing and at less cost.